![](/system/files/ceo-photo/Kevin_Ali_Medium_3-quarter_Shot_2020_FINAL%20%281%29-min.jpg)
![](/system/files/ceo-photo/Kevin_Ali_Medium_3-quarter_Shot_2020_FINAL%20%281%29-min.jpg)
Kevin Ali (M)
Chief Executive Officer
Our purpose is to help women and girls achieve their promise and when we invest in gender equity, we all benefit from the power of her promise. At Organon, we see an opportunity to advance gender equity by promoting women’s leadership at all levels. Signing the UN Women's Women’s Empowerment Principles is another important way we can demonstrate our commitment to creating the gender equity within our company that we want to see in the world.
General Information
WEPs signatory since 08 August 2022
![](https://www.weps.org/sites/default/files/inline-images/uncg-logo.png)
Public
5001-10,000 employees
Baseline
Between 51% and 80% women employees.
Between 30% and 50% women at management level.
Between 51% and 80% women on boards/executive team/partners.
Industry
Pharmaceuticals
Location
United States of America
Global